Hot Products
Catalog No. | Information |
CFN98930 | Mollugin Mollugin is a JAK2 inhibitor and inhibits LPS-induced inflammatory responses by blocking the activation of the JAK-STAT pathway. Mollugin may be a novel therapeutic candidate for bone loss-associated disorders including osteoporosis, rheumatoid arthritis, and periodontitis. Mollugin has anticancer efficacy, can modulate the HER2, HO-1, Nrf2 , and NF- κB pathways. |
CFN92076 | Momordicine I Momordicine I has anti-diabetic and antifeedant activities. |
CFN95167 | Momordicine II Momordicine II may have antidiabetic activity, it significantly stimulated insulin secretion. It also can deter oviposition by L. trifolii significantly. |
CFN95164 | Momordicine V Momordicine V can deter significantly the oviposition by L. trifolii on host plant leaves treated at 26.16 microg/cm2 leaf surface. |
CFN92306 | Momordicoside F1 Momordicoside F1 may have antiproliferative activities against MCF-7, WiDr, HEp-2, and Doay human tumor cell lines. |
CFN97295 | Momordicoside G Momordicosides K and L, the main bitter taste triterpene glycosides in Bitter melon; and bitter melon has been reported to have hypoglycemic, anti atherogenic and anti HIV activities. |
CFN97300 | Momordicoside I aglycone Reference standards. |
CFN92305 | Momordicoside K Momordicoside K has antidiabetic activity. |
CFN92307 | Momordicoside L Momordicoside L has hypoglycaemic / antihyperglycaemic activities. |
CFN92308 | Momordicoside P Reference standards. |